Evidence map›Paper›PMID 29409535›Full record

ArticleJournal of biomedical semantics2018

DMTO: a realistic ontology for standard diabetes mellitus treatment.

Shaker El-Sappagh, Daehan Kwak, Farman Ali, Kyung-Sup Kwak

Abstract read
In one paragraph

Article in Journal of biomedical semantics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. [Ontologies Applied in Clinical Decision Support Systems for Diabetes].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2023
    Review
  10. Article
  11. Ontology for Symptomatic Treatment of Multiple Sclerosis.Healthcare informatics research · 2022
    Article
  12. Article
  13. Review
  14. An ontology network for Diabetes Mellitus in Mexico.Journal of biomedical semantics · 2021
    Article
  15. Article
  16. Article
  17. Article
  18. Biomedical Holistic Ontology for People with Rare Diseases.International journal of environmental research and public health · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shaker El-SappaghInformation Systems Department, Faculty of Computers and Informatics, Benha University, Banha Mansura Road, Meit Ghamr - Benha, Banha, Al Qalyubia Governorate, 3000-104, Egypt. shaker_elsapagh@yahoo.com.
Daehan KwakDepartment of Computer Science, Kean University, Union, NJ, 07083, USA.
Farman AliDepartment of Information and Communication Engineering, Inha University, 100 Inharo, Nam-gu, Incheon, 22212, South Korea.
Kyung-Sup KwakDepartment of Information and Communication Engineering, Inha University, 100 Inharo, Nam-gu, Incheon, 22212, South Korea. kskwak@inha.ac.kr.

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
NRSA Training CoreTL1TR002016 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI THOMAS, GAIL D. · 2016 to 2025
$3.4M
NCATS NIH HHS TL1 TR002016NCATS NIH HHS UL1 TR002014
6 · The paper itself

Abstract

backgroundTreatment of type 2 diabetes mellitus (T2DM) is a complex problem. A clinical decision support system (CDSS) based on massive and distributed electronic health record data can facilitate the automation of this process and enhance its accuracy. The most important component of any CDSS is its knowledge base. This knowledge base can be formulated using ontologies. The formal description logic of ontology supports the inference of hidden knowledge. Building a complete, coherent, consistent, interoperable, and sharable ontology is a challenge.

resultsThis paper introduces the first version of the newly constructed Diabetes Mellitus Treatment Ontology (DMTO) as a basis for shared-semantics, domain-specific, standard, machine-readable, and interoperable knowledge relevant to T2DM treatment. It is a comprehensive ontology and provides the highest coverage and the most complete picture of coded knowledge about T2DM patients' current conditions, previous profiles, and T2DM-related aspects, including complications, symptoms, lab tests, interactions, treatment plan (TP) frameworks, and glucose-related diseases and medications. It adheres to the design principles recommended by the Open Biomedical Ontologies Foundry and is based on ontological realism that follows the principles of the Basic Formal Ontology and the Ontology for General Medical Science. DMTO is implemented under Protégé 5.0 in Web Ontology Language (OWL) 2 format and is publicly available through the National Center for Biomedical Ontology's BioPortal at http://bioportal.bioontology.org/ontologies/DMTO . The current version of DMTO includes more than 10,700 classes, 277 relations, 39,425 annotations, 214 semantic rules, and 62,974 axioms. We provide proof of concept for this approach to modeling TPs.

conclusionThe ontology is able to collect and analyze most features of T2DM as well as customize chronic TPs with the most appropriate drugs, foods, and physical exercises. DMTO is ready to be used as a knowledge base for semantically intelligent and distributed CDSS systems.

Indexed as

Biological OntologiesDiabetes Mellitus, Type 2InternetSemanticsClinical decision support systemDiabetes mellitusKnowledge modelingOntologyTreatment plan

Identifiers

PMID29409535
PMCPMC5800094

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.